Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
Microsoft has cut off access to dozens of its open source projects hosted on GitHub as it investigates how hackers apparently breached the projects and injected password-stealing malware into the code ...
Please provide your email address to receive an email when new articles are posted on . CGM improved HbA1c, time in range and other metrics over 26 weeks. CONNECT trial suggests CGM can be considered ...
Several of those escorted out were scheduled to present at the American Diabetes Association conference this weekend. By Dani Blum Reporting from the American Diabetes Association conference in New ...
Wall Street investors use financial derivatives to hedge against shifts in interest rates and exchange rates. Farmers use them to lock in the price of their crops. Now, one New York City bar is using ...
What Is Afrezza, and Why Does It Matter? Afrezza is a fast-acting insulin that you breathe in as you start a meal. It lowers blood sugar by helping your muscles and fat use sugar and by telling your ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
JPMorgan Chase (JPM) CEO Jamie Dimon issued guidelines on the use of prediction markets by employees, potentially allowing staff to trade on such platforms with caution, Barron's reported on Thursday, ...
A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health ...
PCWorld reports that Windows 11’s new Xbox mode brings console-like gaming performance by disabling unnecessary processes and optimizing for controller navigation. The feature rollout is gradual ...
Gov. JB Pritzker’s administration is setting rules on two emerging technologies for state workers, joining state governments across the country in trying to stay ahead of rapidly shifting terrain. One ...
LAS VEGAS — Off-label use of GLP-1 drugs by people with type 1 diabetes (T1D) did not lead to diabetic ketoacidosis (DKA) or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist ...